Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey

OBJECTIVE To determine the proportion of the population, firstly, with cholesterol ⩾ 5.0 mmol/l and, secondly, with any cholesterol concentration, who might benefit from statin treatment for the following: secondary prevention of coronary heart disease (CHD); primary prevention at CHD risk 30%, 20%,...

Full description

Saved in:
Bibliographic Details
Published in:British heart journal 2001-09, Vol.86 (3), p.289-295
Main Authors: Haq, I U, Ramsay, L E, Wallis, E J, Isles, C G, Ritchie, L D, Jackson, P R
Format: Article
Language:English
Subjects:
Adult
Age
Age Distribution
Angina pectoris
Angina Pectoris - blood
Angina Pectoris - epidemiology
Biological and medical sciences
Blood pressure
Cardiology. Vascular system
Cardiovascular disease
Cardiovascular Medicine
Cholesterol
Cholesterol, HDL - blood
Confidence Intervals
Coronary Disease - blood
Coronary Disease - epidemiology
Coronary Disease - prevention & control
Coronary heart disease
coronary risk
Data analysis
Diabetes
Disease prevention
Female
Health surveys
Heart
Heart attacks
Humans
Hypercholesterolemia - prevention & control
Hypolipidemic Agents - therapeutic use
Male
Medical sciences
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - epidemiology
Peripheral Vascular Diseases - blood
Peripheral Vascular Diseases - epidemiology
Prevalence
primary prevention
Risk Factors
Scotland - epidemiology
secondary prevention
Sex Distribution
Statins
Stroke
Stroke - blood
Stroke - epidemiology
Task forces
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVE To determine the proportion of the population, firstly, with cholesterol ⩾ 5.0 mmol/l and, secondly, with any cholesterol concentration, who might benefit from statin treatment for the following: secondary prevention of coronary heart disease (CHD); primary prevention at CHD risk 30%, 20%, 15%, and 6% over 10 years; and primary prevention at projected CHD risk 20% over 10 years (CHD risk at age 60 years if actual age
ISSN:1355-6037
0007-0769
1468-201X
DOI:10.1136/heart.86.3.289